Drug Therapy
- Perioperative infection: Are we sure what to focus on?
Which immunosuppressive drugs pose the greater danger in the perioperative period: the newer biologics or corticosteroids?
- COVID-19: Coronavirus replication, pathogenesis, and therapeutic strategies
Understanding the virus and how it causes disease points the way to potential treatments.
- Vertebral fractures after denosumab cessation
The patient had a 6-month history of lumbar and dorsal back pain, initially suspected to be facet arthrosis.
- Denosumab cessation
Bone loss is rapid if patients miss injections. Clinicians can take extra measures to ensure patients get appropriate treatment.
- Is it safe to continue biologic agents during surgery in patients with inflammatory bowel disease?
Patients taking monoclonal antibodies can continue taking them, but small-molecule drugs should be withheld.
- Cutaneous adverse effects of biologic medications
These therapies have revolutionized medicine but come with many unique adverse effects.
- Aspirin for primary prevention of atherosclerotic cardiovascular events
A more limited role for aspirin as primary prevention in patients at intermediate risk, with diabetes, and the elderly.